本文发表在 rolia.net 枫下论坛http://www.linkedin.com/in/rcptherapeutics
Gary G. Zhai, Ph.D.
Chief Scientific Officer at Telomolecular Corp
Sacramento, California Area
Pharmaceuticals
Join LinkedIn and access Gary G. Zhai, Ph.D.’s full profile.
As a LinkedIn member, you'll join 175 million other professionals who are sharing connections, ideas, and opportunities. And it's free! You'll also be able to:
See who you and Gary G. Zhai, Ph.D. know in common
Get introduced to Gary G. Zhai, Ph.D.
Contact Gary G. Zhai, Ph.D. directly
View Full Profile
Gary G. Zhai, Ph.D.'s Overview
Current
Chief Scientific Officer at Telomolecular Corp.
Past
Senior Scientific Consultant at Nanobiosym, Inc.
Staff Scientist & Instructor at Massachusetts General Hospital/Harvard Medical School
Lecturer at Henan University Dept of Biology
Education
McGill University
University of Victoria
University of New South Wales
see all
Recommendations
1 person has recommended Gary
Connections
8 connections
Gary G. Zhai, Ph.D.'s Summary
Biochemical science research and technology development/commercialization.
Systemic education and extensive training in biosciences ranging from enzyme structural biology, RNA aptamer selection and characterization, TB antibiotic resistance, cancer therapeutic resistance to nanotechnology therapeutic applications for drug discovery and development of anti-stroke, anti-cancer, and anti-aging regenerative medicines and nanotherapeutics.
Leadership and management experience in both academia and biopharmaceutical industry.
Specialties
Cancer cell signaling transductions, genomic profiling using DNA microarray and real-time PCR, RNA aptamer applications, cancer biology and genetics, nanoparticle formulations and targeting to treat stroke, cancer and aging.
Gary G. Zhai, Ph.D.'s Experience
Chief Scientific Officer
Telomolecular Corp.
Public Company; 11-50 employees; Biotechnology industry
October 2006 – Present (6 years 2 months)
Telomolecular Corp is a biopharmaceutical company focused on developing and commercializing nanotechnology for mitochondrial anti-cancer/anti-aging medicines, nuclear anti-aging/anti-infective telomere therapies, and regenerative therapies.
Senior Scientific Consultant
Nanobiosym, Inc.
Privately Held; 11-50 employees; Nanotechnology industry
March 2006 – September 2006 (7 months)
Staff Scientist & Instructor
Massachusetts General Hospital/Harvard Medical School
Nonprofit; 10,001+ employees; Hospital & Health Care industry
December 2002 – February 2006 (3 years 3 months)
Lecturer
Henan University Dept of Biology
September 1989 – February 1994 (4 years 6 months)
Teaching and conducting research in the field of biochemistry and molecular biology.
Gary G. Zhai, Ph.D.'s Education
McGill University
Postdoc, Infectious Disease
2000 – 2002
Investigate the genetic mechanisms in antibiotic resistance of Mycobacterium avium and Mycobacterium tuberculosis.
University of Victoria
Postdoc, Biochemisry
1998 – 2000
Conducting tumor suppressor protein WT1 RNA aptamer research.
University of New South Wales
1994 – 1998
Shanxi University
M.Sc., Biochemisry
1986 – 1989
Enzyme Kinetics and Structural Biology
Henan University
B.Sc., Chemistry
1982 – 1986更多精彩文章及讨论，请光临枫下论坛 rolia.net